OptimizeRx Corp. announced the appointment of Steve Silvestro, its Chief Executive Officer, to the Board of Directors, effective June 20, 2025. Mr. Silvestro has served as CEO since March 2025, following his tenure as interim CEO from January 2025.
This appointment is expected to enhance overall leadership and contribute significantly to the company's ability to execute its value creation plans. Mr. Silvestro's deep knowledge of the company and industry expertise are seen as valuable additions to the board.
The Board of Directors expressed confidence in Mr. Silvestro's leadership and the progress made since he assumed the CEO role. His presence on the board aims to further refine and advance the company’s strategic direction.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.